Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: brd3b ENSDARG00000100129

.

Description

bromodomain containing 3b [Source:NCBI gene (formerly Entrezgene);Acc:327108]

Location

Chromosome 5: 64,411,516-64,454,466 reverse strand.

GRCz11:CM002889.2

About this gene

This gene has 3 transcripts (splice variants), 18 orthologues and 14 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSDART00000168030.2	brd3b-202	4755	664aa	ENSDARP00000129878.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0AB32TTD7	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000172321.2	brd3b-203	2168	625aa	ENSDARP00000141933.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	3' truncation in transcript evidence prevents annotation of the end of the CDS.CDS 3' incomplete,
ENSDART00000158248.2	brd3b-201	911	304aa	ENSDARP00000136696.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	5' and 3' truncations in transcript evidence prevent annotation of the start and the end of the CDS.CDS 5' and 3' incomplete,

.

Summary

.

.